share_log

Telesis Bio Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Results and Raised FY22 Guidance.

Benzinga ·  Nov 8, 2022 17:36
Telesis Bio shares are trading higher after the company reported better-than-expected Q3 results and raised FY22 guidance.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment